Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive
Open accessAbstract
Objectives This study was designed to examine whether the occurrence of left ventricular hypertrophy (LVH) in moderate to severe essential hypertension (EHT) was associated with alteration in peripheral sympathetic drive.Background In hypertension, LVH is an independent predictor of increased morbidity and mortality. The reported mechanisms leading to LVH remain unclear but include hemodynamic and humoral factors. The sympathetic nervous system may be important, particularly as catecholamines have been shown to have trophic properties. We tested the hypothesis that sympathetic activity measured using microneurography could be different in patients with hypertension depending on the presence of LVH.Methods We examined 28 subjects with moderate to severe EHT (stages 2 to 3; Joint National Committee [JNC]-VI classification). Fourteen had echocardiographic evidence of LVH (EHT + LVH), while the other 14 subjects (EHT) did not. Subjects were matched in terms of age, body mass index and levels of arterial blood pressure. Peripheral muscle sympathetic nerve activity was measured from both multiunit bursts (MSNA) and single unit (s-MSNA) vasoconstrictor impulses via the peroneal nerve.Results The mean frequency of s-MSNA and MSNA was greater in the EHT + LVH group than it was in the EHT group (mean +/- SEM; 75.9 +/- 6.9 impulses/100 beats vs. 52.1 +/- 2.9 impulses/100 beats, p < 0.001 and 64.2 +/- 5.7 bursts/100 beats vs. 48.9 +/- 2.8 bursts/100 beats, p < 0.05).Conclusions These results indicate that, in subjects with moderate to severe hypertension, the presence of LVH is associated with higher sympathetic discharge, evidenced by an increase in unitary firing frequency and also by fiber recruitment.
AI snapshot
Written from the paper’s full text.
TL;DR
In moderate-to-severe essential hypertension, patients with echocardiographic left ventricular hypertrophy had higher resting peripheral sympathetic discharge than matched patients without LVH. The authors conclude that central sympathetic hyperactivity may be a factor in the development of hypertensive LVH.
Key findings
- Single-unit muscle sympathetic nerve activity (s-MSNA) was greater in EHT + LVH than in EHT without LVH: 75.9 ± 6.9 vs. 52.1 ± 2.9 impulses/100 beats, p < 0.001.
- Multiunit MSNA was also greater in EHT + LVH: 64.2 ± 5.7 vs. 48.9 ± 2.8 bursts/100 beats, p < 0.05.
- Per-minute differences did not reach significance: s-MSNA 51.1 ± 5.3 vs. 38.1 ± 2.4 impulses/min (p > 0.05); MSNA 40.6 ± 2.5 vs. 35.5 ± 2.1 bursts/min (p > 0.05).
- s-MSNA and MSNA per 100 cardiac beats correlated with left ventricular mass index (r = 0.48 and r = 0.46, respectively; p < 0.05).
Methods
- Cross-sectional study of 28 Caucasian patients with newly diagnosed moderate-to-severe essential hypertension (JNC-VI stages 2–3): 14 with echocardiographic LVH and 14 without LVH, matched for age, body weight, body mass index, and arterial blood pressure.
- Peripheral muscle sympathetic nerve activity was recorded from the right peroneal nerve using microneurography, measuring both multiunit bursts (MSNA) and single-unit vasoconstrictor impulses (s-MSNA); LVH was assessed by M-mode echocardiography.
- Two-way ANOVA with Bonferroni post-test comparisons and least-squares linear correlation were used; data are mean ± SEM.
Limitations
- The paper states that human autonomic studies are constrained by limited techniques for directly quantifying sympathetic activity; microneurography records from a peripheral nerve, and reflex sympathetic activation is heterogeneous, though this study was performed at rest.
- The paper states that this was a cross-sectional study, so it implies association but gives no direct evidence of causality, and that many additional factors are important in LVH development.
- Evident from the text: the sample was small (28 patients), 6 of 14 EHT + LVH patients were already on antihypertensive therapy before the study (omitted only on the study day), and there was some overlap in left ventricular mass between groups.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 51 cited sources checked · 0 supported · 0 flagged
- Findingown data§ Results
The mean frequency of MSNA per minute was not significantly different between the EHT+LVH and EHT groups.
“The group mean frequency of MSNA in EHT + LVH versus EHT was 40.6 ± 2.5 bursts/min versus 35.5 ± 2.1 bursts/min (p > 0.05) and 64.2 ± 5.7 bursts/100 beats versus 48.9 ± 2.8 bursts/100 beats (p < 0.05).”
Quote in the paperNot a substantial claim - Findingown data§ Results
Posterior wall thickness was greater in the EHT+LVH group than in the EHT group.
“Respectively, for the EHT + LVH and the EHT groups, posterior wall thickness was 13 ± 0.8 mm and 10 ± 0.3 mm (p < 0.05); interventricular septal thickness was 12 ± 0.8 mm and 10 ± 0.3 mm (p > 0.05), and end-diastolic volumes were 124 ± 12.4 ml and 127 ± 15.8 ml (p > 0.8).”
Quote in the paperSubstantial claim - Findingown data§ Results
Left ventricular mass index was greater in the EHT+LVH group than in the EHT group.
“The estimated LVM in the EHT + LVH group was 301 ± 26.6 g and in the EHT group was 215 ± 19 g (p < 0.05), and the values for LVMI when indexed by body surface area were 155 ± 13 g/m2and 113 ± 10.9 g/m2for the two groups, respectively (p < 0.05).”
Quote in the paperSubstantial claim - Findingown data§ RESULTS
In patients with moderate to severe essential hypertension, the mean frequency of single-unit muscle sympathetic nerve activity (s-MSNA) per 100 cardiac beats is greater in those with left ventricular hypertrophy (LVH) than in those without LVH.
“The mean frequency of s-MSNA and MSNA was greater in the EHT + LVH group than it was in the EHT group (mean ± SEM; 75.9 ± 6.9 impulses/100 beats vs. 52.1 ± 2.9 impulses/100 beats, p < 0.001 and 64.2 ± 5.7 bursts/100 beats vs. 48.9 ± 2.8 bursts/100 beats, p < 0.05).”
- Also stated in: § Results · plain
“The group mean frequency of s-MSNA in EHT + LVH versus EHT was 51.1 ± 5.3 impulses/min versus 38.1 ± 2.4 impulses/min (p > 0.05) and 75.9 ± 6.9 impulses/100 beats versus 52.1 ± 2.9 impulses/100 beats (p < 0.001).”
- Also stated in: § Discussion · plain
“In this study, the resting mean discharge frequency of s-MSNA per 100 cardiac beats in the patients with EHT + LVH was significantly greater (by about 46%) than that in the EHT group.”
Quote in the paperSubstantial claim - Also stated in: § Results · plain
- Findingown data§ Results
Within each group, there was no significant correlation between resting sympathetic discharge (s-MSNA or MSNA) and resting arterial blood pressure or heart rate.
“However, there was no significant correlation within any group (consistently r< 0.38, p > 0.09) between resting sympathetic discharge (s-MSNA or MSNA) and the levels of resting arterial blood pressure (systolic, diastolic or mean pressure) or heart rate.”
Quote in the paperNot a substantial claim
- Findingown data§ RESULTS
In patients with moderate to severe essential hypertension, the mean frequency of multiunit muscle sympathetic nerve activity (MSNA) per 100 cardiac beats is greater in those with LVH than in those without LVH.
“The mean frequency of s-MSNA and MSNA was greater in the EHT + LVH group than it was in the EHT group (mean ± SEM; 75.9 ± 6.9 impulses/100 beats vs. 52.1 ± 2.9 impulses/100 beats, p < 0.001 and 64.2 ± 5.7 bursts/100 beats vs. 48.9 ± 2.8 bursts/100 beats, p < 0.05).”
- Also stated in: § Results · plain
“The group mean frequency of MSNA in EHT + LVH versus EHT was 40.6 ± 2.5 bursts/min versus 35.5 ± 2.1 bursts/min (p > 0.05) and 64.2 ± 5.7 bursts/100 beats versus 48.9 ± 2.8 bursts/100 beats (p < 0.05).”
- Also stated in: § Discussion · plain
“Assessment from multiunit MSNA bursts revealed that the EHT + LVH group still had about 31% greater sympathetic activity than the EHT group.”
Quote in the paperSubstantial claim - Also stated in: § Results · plain
- Findingown data§ Results
Interventricular septal thickness did not differ significantly between the EHT+LVH and EHT groups.
“Respectively, for the EHT + LVH and the EHT groups, posterior wall thickness was 13 ± 0.8 mm and 10 ± 0.3 mm (p < 0.05); interventricular septal thickness was 12 ± 0.8 mm and 10 ± 0.3 mm (p > 0.05), and end-diastolic volumes were 124 ± 12.4 ml and 127 ± 15.8 ml (p > 0.8).”
Quote in the paperNot a substantial claim - Findingown data§ Results
The mean frequency of s-MSNA per minute was not significantly different between the EHT+LVH and EHT groups.
“The group mean frequency of s-MSNA in EHT + LVH versus EHT was 51.1 ± 5.3 impulses/min versus 38.1 ± 2.4 impulses/min (p > 0.05) and 75.9 ± 6.9 impulses/100 beats versus 52.1 ± 2.9 impulses/100 beats (p < 0.001).”
Quote in the paperNot a substantial claim - Findingown data§ Results
Estimated left ventricular mass was greater in the EHT+LVH group than in the EHT group.
“The estimated LVM in the EHT + LVH group was 301 ± 26.6 g and in the EHT group was 215 ± 19 g (p < 0.05), and the values for LVMI when indexed by body surface area were 155 ± 13 g/m2and 113 ± 10.9 g/m2for the two groups, respectively (p < 0.05).”
Quote in the paperSubstantial claim - Findingreasoning§ Discussion
There was a degree of overlap in left ventricular mass between the two groups.
“Although there was a significant difference in LVM between the two groups, there was a degree of overlap in the data.”
Quote in the paperNot a substantial claim - Findingreasoning§ Discussion
In patients with essential hypertension and left ventricular hypertrophy, the increased sympathetic activity was still apparent despite the use of agents that may have attenuated the group differences.
“was still apparent despite the use of agents that may have attenuated the group differences, thus adding further weight to the findings.”
Quote in the paperSubstantial claim - Findingreasoning§ Discussion
In patients with essential hypertension and left ventricular hypertrophy, the increased sympathetic activity was not attributable to antihypertensive treatment.
“the increased activity in EHT + LVH was not attributable to antihypertensive treatment”
Quote in the paperSubstantial claim - Interpretationnone given§ Discussion
Increased s-MSNA represents a true increase in the discharge frequency of central sympathetic neurons.
“First, increased s-MSNA represents a true increase in the discharge frequency of central sympathetic neurons.”
Quote in the paperNot a substantial claim - Interpretationown data§ Discussion
The increased sympathetic activity in EHT+LVH was not attributable to antihypertensive treatment.
“Therefore, the increased activity in EHT + LVH was not attributable to antihypertensive treatment and, in fact, was still apparent despite the use of agents”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [29] Greenwood, 1998, Effect of atenolol therapy on peripheral sympathetic nerve discharge in essential hypertension, J Hypertens
Not checked in the free run.
- cites [30] Wallin, 1984, Sympathetic outflow to muscles during treatment of hypertension with metoprolol, Hypertension source
Not checked in the free run.
- cites [31] Grassi, 1998, Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension, J Hypertens source
Not checked in the free run.
- cites [32] Matsukawa, 1993, Elevated sympathetic nerve activity in patients with accelerated essential hypertension, J Clin Invest source
Not checked in the free run.
- Study design and conductown data§ Results
When only the 22 untreated patients were considered, the LVH group still had significantly greater sympathetic discharge compared with the non-LVH group.
“When only the 22 untreated patients were considered (8 in the EHT + LVH group vs. 14 in the EHT group), the overall findings were unaltered in that the LVH group still had significantly greater sympathetic discharge compared with the non-LVH group.”
Quote in the paperSubstantial claim - Study design and conductown data§ Results
Within the EHT+LVH group, there was no significant difference in any measure of sympathetic discharge between treated and untreated patients.
“Within the group of EHT + LVH, there was no significant difference in any measure of sympathetic discharge between those who were treated and those untreated (Figs. 2 and 3).”
Quote in the paperNot a substantial claim - Premisecitation§ CONCLUSIONS
In essential hypertension, elevated arterial pressure has been associated with increased central sympathetic output to the heart, kidney and skeletal muscles.
“In essential hypertension (EHT), the elevated arterial pressure has been associated with increased central sympathetic output to the heart, kidney and skeletal muscles (11–13).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [11] Julius, 1996, Sympathetic overactivity in hypertension. A moving target, Am J Hypertens source
Not checked in the free run.
- cites [12] Mark, 1990, Regulation of sympathetic nerve activity in mild human hypertension, J Hypertens
Not checked in the free run.
- cites [13] Esler, 1990, Increased regional sympathetic nervous activity in human hypertension, J Hypertens
Not checked in the free run.
- Study design and conductcitation§ Discussion
Under resting conditions, the variability between repeat recordings of both s-MSNA and MSNA is less than 8%.
“Finally, although the technique of microneurography is selective for the particular unit(s) studied, under resting conditions the variability between repeat recordings of both s-MSNA and MSNA is <8% (16).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] Greenwood, 1999, Single unit sympathetic discharge, Circulation source
Not checked in the free run.
- Premisecitation§ CONCLUSIONS
In stage 1 hypertensive disease, peripheral sympathetic drive is higher than in more severe degrees of hypertension.
“more recently, we have shown that, in stage 1 hypertensive disease, the peripheral sympathetic drive is, in fact, higher than that found in the more severe degrees of hypertension (16).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] Greenwood, 1999, Single unit sympathetic discharge, Circulation source
Not checked in the free run.
- Interpretationown data§ Discussion
This is the first evidence that the mean resting frequency of peripheral sympathetic vasoconstrictor discharge in moderate to severe hypertension was greater in those patients with LVH compared with those without LVH.
“This is the first evidence that the mean resting frequency of peripheral sympathetic vasoconstrictor discharge in moderate to severe hypertension was greater in those patients with LVH compared with those without LVH.”
Quote in the paperSubstantial claim - Premisecitation§ Discussion
Isolated ventricular distension has only a small effect on systemic perfusion pressure (vascular resistance) until distension is excessive.
“recent experimental evidence suggests that isolated ventricular distension has only a small effect on systemic perfusion pressure (vascular resistance) until distension is excessive (39).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [39] Wright, 2000, Reflex effects of independent stimulation of coronary and left ventricular mechanoreceptors in anaesthetised dogs, J Physiol (Lond) source
Not checked in the free run.
- Interpretationreasoning§ Discussion
These findings help to reconcile differing reports on sympathetic hyperactivity in hypertension.
“These findings also help to reconcile differing reports on sympathetic hyperactivity in hypertension.”
Quote in the paperSubstantial claim - Interpretationown data§ Conclusions
Central sympathetic hyperactivity may be a factor in the development of hypertensive left ventricular hypertrophy.
“This supports the hypothesis that central sympathetic hyperactivity may be a factor in the development of hypertensive LVH.”
Quote in the paperSubstantial claim - Premisecitation§ CONCLUSIONS
Patients with hypertension who have peripheral vascular disease have a greater degree of LVH than those without LVH.
“Indeed, it is known that patients with hypertension who have peripheral vascular disease have a greater degree of LVH than those without LVH (20)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [20] Brahimi, 1998, Factors determining cardiac hypertrophy in hypertensive patients with or without peripheral vascular disease, Clin Sci (Colch) source
Not checked in the free run.
- Interpretationown data§ Discussion
The finding that established hypertension complicated by left ventricular hypertrophy is associated with more marked sympathetic hyperactivity than uncomplicated hypertension of equal severity suggests the possibility of different subgroups within the hypertensive population.
“The finding that established hypertension complicated by LVH is associated with a more marked sympathetic hyperactivity than uncomplicated hypertension of equal severity suggests the possibility of different subgroups within the hypertensive population.”
Quote in the paperSubstantial claim - Interpretationreasoning§ Discussion
The apparent contradictory results in the two studies can be explained in a manner entirely consistent with the current findings.
“Thus, the apparent contradictory results in these two studies can be explained in a manner entirely consistent with the current findings.”
Quote in the paperSubstantial claim - Interpretationreasoning§ Discussion
Patients destined to develop left ventricular hypertrophy or vascular hypertrophy are more likely to maintain, or further increase, their marked sympathetic hyperactivity.
“it may be reasonable to postulate that patients destined to develop LVH or vascular hypertrophy are more likely to maintain, or further increase, their marked sympathetic hyperactivity.”
Quote in the paperSubstantial claim - Premisecitation§ Discussion
In human studies, indexes of left ventricular mass have tended to correlate with plasma norepinephrine values and cardiac noradrenaline spillover.
“Also, in human studies, indexes of LVM have tended to correlate with plasma norepinephrine values (37)and cardiac noradrenaline spillover (38).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [37] Marcus, 1994, Sex-specific determinants of increased left ventricular mass in the Tecumseh blood pressure study, Circulation source
Not checked in the free run.
- cites [38] Kelm, 1996, Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients, J Hypertens source
Not checked in the free run.
- Premisecitation§ Discussion
Measures of cardiac norepinephrine spillover correlate well with recordings of peripheral sympathetic nerve activity.
“Importantly, however, evidence does suggest that measures of cardiac norepinephrine spillover do correlate well with recordings of peripheral sympathetic nerve activity (41).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] Wallin, 1992, Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans, J Physiol (Lond) source
Not checked in the free run.
- Premisecitation§ Discussion
Treatment with angiotensin-converting enzyme inhibitors in hypertension has been shown to have either no effect or decrease sympathetic nerve traffic.
“Also, treatment with angiotensin-converting enzyme inhibitors in hypertension has been shown to have either no effect or decrease sympathetic nerve traffic (31,32).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [31] Grassi, 1998, Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension, J Hypertens source
Not checked in the free run.
- cites [32] Matsukawa, 1993, Elevated sympathetic nerve activity in patients with accelerated essential hypertension, J Clin Invest source
Not checked in the free run.
- Premisecitation§ Discussion
Stimulation of mechanoreceptors in the walls of the atria and vein-atrial junctions does not affect the discharge in peripheral sympathetic nerves.
“stimulation of mechanoreceptors in the walls of the atria and vein-atrial junctions has been shown not to affect the discharge in peripheral sympathetic nerves (40).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [40] Karim, 1972, The effects of stimulation of the left atrial receptors on sympathetic efferent nerve activity, J Physiol (Lond) source
Not checked in the free run.
- Study design and conductown data§ Discussion
Qualitatively, both s-MSNA and MSNA measures responded to reflex maneuvers in a manner that reflected their involvement in peripheral vascular control.
“Qualitatively, both measures responded to reflex maneuvers in a manner that reflected their involvement in peripheral vascular control.”
Quote in the paperNot a substantial claim
- May combine two claims. 21
- Classified as probably not a substantial claim. 15
May combine two claims.
Findingown data§ ResultsThere was a significant positive correlation between both s-MSNA and MSNA quantified per 100 cardiac beats and left ventricular mass index.
“there was a significant correlation between both s-MSNA and MSNA (quantified per 100 cardiac beats) and LVMI (always p < 0.05; r= 0.48 and r= 0.46, respectively).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown data§ ResultsThere was a significant positive correlation between resting s-MSNA and MSNA and age across subjects.
“As expected, there was a significant positive correlation (r) for resting s-MSNA and MSNA with the subjects age (rat least 0.42 and at most 0.59; p < 0.0002).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingcitation§ DiscussionThe results obtained from MSNA recordings in this study were similar to those previously published in age-comparable hypertensive subjects.
“The results obtained from MSNA recordings in this study were similar to those previously published in age-comparable hypertensive subjects (15,16,25,26,28).”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [15] Grassi, 1998, Baroreflex control of sympathetic nerve activity in essential and secondary hypertension, Hypertension source
Not checked in the free run.
- cites [16] Greenwood, 1999, Single unit sympathetic discharge, Circulation source
Not checked in the free run.
- cites [25] Yamada, 1989, Age-related changes in muscle sympathetic nerve activity in essential hypertension, Hypertension source
Not checked in the free run.
- cites [26] Matsukawa, 1991, Reduced baroreflex changes in muscle sympathetic nerve activity during blood pressure elevation in essential hypertension, J Hypertens source
Not checked in the free run.
- cites [28] Miyajima, 1991, Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism, Hypertension source
Not checked in the free run.
May combine two claims.
Findingown data§ DiscussionIn patients with moderate to severe essential hypertension, the presence of left ventricular hypertrophy is associated with higher resting sympathetic discharge, evidenced by both an increase in unitary firing frequency and by fiber recruitment, compared with subjects without left ventricular hypertrophy.
“The results of this investigation suggest that the occurrence of LVH in EHT is associated with an increase in magnitude of the sympathetic hyperactivity compared with that in subjects without LVH.”
- Also stated in: § Conclusions · boosted
“This is the first evidence that, in patients with moderate to severe EHT, the presence of LVH is associated with higher resting sympathetic discharge, evidenced by both an increase in unitary firing frequency and by fiber recruitment.”
Quote in the paperSubstantial claim- Also stated in: § Conclusions · boosted
May combine two claims.
Study design and conductown data§ ResultsThere was no significant difference in age, body weight, body mass index, heart rate or arterial blood pressure between the EHT+LVH and EHT groups.
“There was no significant difference in age, body weight, body mass index, heart rate or arterial blood pressure between the groups.”
- Also stated in: § Methods · plain
“these were matched in terms of age, body weight, body mass index and levels of arterial blood pressure.”
Quote in the paperSubstantial claim- Also stated in: § Methods · plain
May combine two claims.
Interpretationreasoning§ DiscussionIncreased MSNA represents central activation as well as reflex-based increases (fiber recruitment) in sympathetic activity.
“Second, increased MSNA represents central activation as well as reflex-based increases (fiber recruitment) in sympathetic activity.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown data§ DiscussionThe relative sympathetic hyperactivity in EHT+LVH reflected an increased central output at rest and was not caused by differences in arterial blood pressure, age or body weight.
“This relative sympathetic hyperactivity reflected an increased central output at rest and was not caused by differences in arterial blood pressure, age or body weight.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ CONCLUSIONSIn patients with hypertension, the occurrence of LVH has been associated with an increase in mortality from all cardiovascular causes.
“In patients with hypertension, the occurrence of left ventricular hypertrophy (LVH) has been associated with an increase in mortality from all cardiovascular causes (1–4).”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [1] Levy, 1990, Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart study, N Engl J Med source
Not checked in the free run.
- cites [2] Koren, 1991, Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension, Ann Intern Med source
Not checked in the free run.
- cites [3] Kannel, 1992, Left ventricular hypertrophy as a risk factor in arterial hypertension, Eur Heart J source
Not checked in the free run.
- cites [4] Gueyffier, 1999, Identification of risk factors in hypertensive patients, Circulation source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
Premisecitation§ DiscussionMicroneurography is a well-established technique that has been used successfully in the assessment of peripheral sympathetic activity.
“Microneurography is a well-established technique that has been used successfully in the assessment of peripheral sympathetic activity (14).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [14] Wallin, 1993, Assessment of sympathetic mechanisms for recordings of postganglionic efferent nerve traffic
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ DiscussionPatients with hypertension have a greater frequency of MSNA bursts than properly matched normotensive subjects.
“Despite the difficulty of establishing that every unit within a burst has a vasoconstrictor role, there is a wealth of evidence to suggest that patients with hypertension have a greater frequency of MSNA bursts than properly matched normotensive subjects (15,25–27).”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [15] Grassi, 1998, Baroreflex control of sympathetic nerve activity in essential and secondary hypertension, Hypertension source
Not checked in the free run.
- cites [25] Yamada, 1989, Age-related changes in muscle sympathetic nerve activity in essential hypertension, Hypertension source
Not checked in the free run.
- cites [26] Matsukawa, 1991, Reduced baroreflex changes in muscle sympathetic nerve activity during blood pressure elevation in essential hypertension, J Hypertens source
Not checked in the free run.
- cites [27] Floras, 1993, Sympathoneural and haemodynamic characteristics of young subjects with mild essential hypertension, J Hypertens source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation§ CONCLUSIONSThe development of LVH has been attributed to many factors, including raised arterial pressure levels and growth-promoting substances such as angiotensin II, insulin-like growth factor-1 and circulating catecholamines.
“The development of LVH has been attributed to many factors, including raised arterial pressure levels (resulting in increased myocardial workload) and growth-promoting substances such as angiotensin II, insulin-like growth factor-1 and circulating catecholamines (5–10).”
Quote in the paperNot a substantial claim0 of 6 sources checked- cites [5] Lauer, 1991, Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry, J Am Coll Cardiol source
Not checked in the free run.
- cites [6] Bauwens, 1991, Influence of the arterial blood pressure and nonhemodynamic factors on left ventricular hypertrophy in moderate essential hypertension, Am J Cardiol source
Not checked in the free run.
- cites [7] Duprez, 1993, Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension, Am J Cardiol source
Not checked in the free run.
- cites [8] Harrap, 1996, Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults, Circulation source
Not checked in the free run.
- cites [9] Verdecchia, 1999, Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension, Circulation source
Not checked in the free run.
- cites [10] Julius, 1998, Effect of sympathetic overactivity on cardiovascular prognosis in hypertension, Eur Heart J
Not checked in the free run.
May combine two claims.
Interpretationown data§ CONCLUSIONSIn subjects with moderate to severe hypertension, the presence of LVH is associated with higher sympathetic discharge, evidenced by an increase in unitary firing frequency and also by fiber recruitment.
“These results indicate that, in subjects with moderate to severe hypertension, the presence of LVH is associated with higher sympathetic discharge, evidenced by an increase in unitary firing frequency and also by fiber recruitment.”
Quote in the paperSubstantial claimMay combine two claims.
Premisecitation§ DiscussionIn patients with moderate to severe hypertension, sympathetic output was lower or equal compared with matched groups with milder hypertension, depending on whether single units or multiunits were examined.
“More recently, we have shown that patients with moderate to severe hypertension had either lower or equal sympathetic output compared with matched groups with milder hypertension, depending on whether single units or multiunits were examined (16).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] Greenwood, 1999, Single unit sympathetic discharge, Circulation source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
Study design and conductreasoning§ DiscussionThis was a cross-sectional study, which implies an association but gives no direct evidence of causality.
“One final point to remember is that this was a cross-sectional study, which, although it implies an association, gives no direct evidence of causality.”
Quote in the paperSubstantial claimMay combine two claims.
Premisecitation§ DiscussionThe onset of hypertension is associated with sympathetic hyperactivity, while eventually the severity of hypertension is maintained, in part, by the occurrence of end-organ structural changes.
“These findings have provided support to the theory that the onset of hypertension is associated with sympathetic hyperactivity, while, eventually, the severity of hypertension is maintained, in part, by the occurrence of end-organ structural changes (11,34).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
Premisecitation§ DiscussionIn the former study, subjects with severe hypertension had a high left ventricular mass index, whereas in the latter study left ventricular hypertrophy was excluded.
“Finally, and perhaps most importantly, subjects with severe hypertension in the former study had a high LVMI, whereas, in the latter study, LVH was excluded.”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
Premisecitation§ DiscussionChronic administration of atenolol or metoprolol may have either no effect on or reduce the resting mean frequency of sympathetic discharge in essential hypertension.
“However, chronic administration, as in this study, with agents such as atenolol (29)and metoprolol (30)may, respectively, have either no effect on or reduce the resting mean frequency of sympathetic discharge in EHT.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [29] Greenwood, 1998, Effect of atenolol therapy on peripheral sympathetic nerve discharge in essential hypertension, J Hypertens
Not checked in the free run.
- cites [30] Wallin, 1984, Sympathetic outflow to muscles during treatment of hypertension with metoprolol, Hypertension source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone given§ MethodsData analysis was performed off-line by a single experienced operator without knowledge of the patient diagnosis.
“Without knowledge of the patient diagnosis, data analysis was performed off-line by a single experienced operator using signal-processing software (FASTDAQ, Lectromed UK Ltd.).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ MethodsNeural activity was expressed both per minute and per 100 cardiac beats because there is a complex relationship between heart rate and sympathetic discharge frequency, and the latter expression avoids interference by the length of the cardiac cycle.
“Neural activity was expressed both per min and per 100 cardiac beats as it is understood that there is a complex relationship between heart rate and sympathetic discharge frequency, and the latter expression avoids any interference by the length of the cardiac cycle (24).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] Sundlöf, 1977, The variability of muscle nerve sympathetic activity in resting recumbent man, J Physiol (Lond) source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone given§ MethodsThe study group was recruited from among 34 patients; in 6 patients it was not possible to obtain stable microneurographic data.
“The study group was recruited from among 34 patients; in 6 patients it was not possible to obtain stable microneurographic data.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation§ DiscussionBlood pressure classification differed between the two studies, the former using an arbitrary classification and the latter using the JNC-VI classification.
“First, blood pressure classification differed between the studies, the former using an arbitrary classification and the latter using the JNC-VI classification (21).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [21] 1997, The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure, Arch Intern Med source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable).
Interpretationreasoning§ DiscussionUsing a combination of single and multiunit assessment may have allowed further characterization of the hypertensive subjects.
“Thus, using a combination of single and multiunit assessment may have allowed further characterization of the hypertensive subjects.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation§ DiscussionCatecholamines have trophic properties on cardiac myocytes and in the intact animal heart.
“In support of this, catecholamines have been shown experimentally to have trophic properties on cardiac myocytes (35)and in the intact animal heart (36).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [35] Simpson, 1983, Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha-1 adrenergic response, J Clin Invest source
Not checked in the free run.
- cites [36] Sen, 1986, Cardiovascular hypertrophy in spontaneously hypertensive rats, J Hypertens
Not checked in the free run.
Classified as probably not a substantial claim.
Premisecitation§ CONCLUSIONSIncreased sympathetic drive enhances vascular hypertrophy.
“and that increased sympathetic drive enhances vascular hypertrophy (10).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Julius, 1998, Effect of sympathetic overactivity on cardiovascular prognosis in hypertension, Eur Heart J
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
Study design and conductcitation§ MethodsOnly vasoconstrictor activity was accepted and examined, with acceptance criteria being appropriate responses to spontaneous changes in arterial blood pressure, the Valsalva maneuver and isometric hand-grip exercise.
“Only vasoconstrictor activity was accepted and examined, the criteria of acceptance being appropriate responses to spontaneous changes in arterial blood pressure, the Valsalva maneuver and isometric hand-grip exercise, as previously described (16,17).”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone given§ DiscussionMicroneurography recordings are made from a peripheral nerve, although microneurography has been considered the only technique available to directly record sympathetic activity in human subjects.
“Although microneurography has been considered the only technique available to “directly” record sympathetic activity in human subjects, recordings are made from a peripheral nerve.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown data§ DiscussionEven if the EHT group had some degree of LVH, it remains valid that the EHT+LVH group with a greater degree of LVH have greater sympathetic activation.
“However, even if we hypothesize that the EHT group had some degree of LVH (to explain the overlap), it remains valid that the EHT + LVH group with a greater degree of LVH have greater sympathetic activation.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
Study design and conductnone given§ DiscussionThe fundamental problem of all studies of human autonomic control is the constraint imposed by the limited techniques available to actually quantify sympathetic activity.
“The fundamental problem of all studies of human autonomic control is the constraint imposed by the limited techniques available to actually quantify sympathetic activity.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductnone given§ DiscussionRecording neural activity from a single sympathetic unit allows further insight into central command and a true assessment of central sympathetic discharge frequency.
“Secondly, we have shown that the ability to record neural activity from a single sympathetic unit allows further insight into central command, as it allows a true assessment of central sympathetic discharge frequency.”
Quote in the paperSubstantial claim
The paper relies on this without support.
Catecholamines have trophic properties.
“particularly as catecholamines have been shown to have trophic properties.”
The paper relies on this without support.
The reasons why not all hypertensive subjects develop LVH remain undetermined.
“However, not all subjects go on to develop LVH, and the reasons for this remain undetermined.”
The paper relies on this without support.
It remains unknown whether hypertensive patients who have developed LVH have altered sympathetic drive compared with those without LVH who have similar blood pressure levels.
“Thus, it remains unknown whether hypertensive patients who have developed LVH have altered sympathetic drive compared with those without LVH who have similar blood pressure levels.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Microneurographic studies almost universally show that sympathetic nerve traffic is potentiated in established hypertension in middle age and in elderly as well as young patients.
“As far as the second issue is concerned, microneurographic studies almost universally shown that sympathetic nerve traffic is potentiated in established hypertension in middle age and in elderly as well as young patients38–46.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [40]
Adrenergic neural factors may contribute to the development and progression of target organ damage, as documented by pronounced increases in sympathetic nerve traffic and cardiac norepinephrine spillover rate in patients with hypertension complicated by left ventricular hypertrophy or left ventricular diastolic dysfunction.
“Adrenergic neural factors may also contribute to the development and progression of target organ damage, as documented by the pronounced increase in sympathetic nerve traffic and cardiac norepinephrine spillover rate in patients in which hypertension is complicated by left ventricular hypertrophy or left ventricular diastolic dysfunction40,42,44,45.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [40]
The sympathetic neural outflow is commonly activated also to the heart and skeletal muscle vasculature, but renal sympathetic activation is central to hypertension pathogenesis.
“The sympathetic neural outflow is commonly activated also to the heart, shown with selective cardiac norepinephrine spillover measurements28, and to the skeletal muscle vasculature, demonstrated with microneurographic nerve traffic recording32,33,38–46, but it is the renal sympathetic activation which is central to hypertension pathogenesis96–97.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [40]
Cites
Sahn, D. J., DeMaria, A. N., KISSLO, J. A., & Weyman, A. E. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430 · see citing works
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.21.2413 · Cited by 6,345 · see citing works
Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I., & Reichek, N. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90771-x · Cited by 6,226 · see citing works
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699 · see citing works
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777 · see citing works
Koren, M. J., Devereux, R. B., Casale, P. N., Savage, D. D., & Laragh, J. H. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-5-345 · Cited by 2,366 · see citing works
Physiological aspects of primary hypertension.
Folkow, B. (1982) · Physiological Reviews · doi:10.1152/physrev.1982.62.2.347 · Cited by 1,768 · see citing works
Anderson, E. A., Sinkey, C. A., Lawton, W. J., & Mark, A. L. (1989) · Hypertension · doi:10.1161/01.hyp.14.2.177 · Cited by 632 · see citing works
Simpson, P. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111023 · Cited by 618 · see citing works
Baroreflex Control of Sympathetic Nerve Activity in Essential and Secondary Hypertension
Grassi, G., Cattaneo, B. M., Seravalle, G., Lanfranchi, A., & Mancia, G. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.68 · Cited by 526 · see citing works
The variability of muscle nerve sympathetic activity in resting recumbent man
Sundlöf, G., & Wallin, B. G. (1977) · The Journal of Physiology · doi:10.1113/jphysiol.1977.sp012050 · Cited by 442 · see citing works
Wallin, B. G., Esler, M., Dorward, P., Eisenhofer, G., Ferrier, C., Westerman, R., & Jennings, G. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019217 · Cited by 298 · see citing works
The discharge behaviour of single vasoconstrictor motoneurones in human muscle nerves
Macefield, V. G., Wallin, B. G., & Vallbo, A. B. (1994) · The Journal of Physiology · doi:10.1113/jphysiol.1994.sp020482 · Cited by 248 · see citing works
Sympathetic overactivity in hypertension. A moving target
JULIUS, S., & NESBITT, S. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(96)00287-7 · Cited by 237 · see citing works
Echocardiographic assessment of left ventricular hypertrophy
Reichek, N. (1982) · European Heart Journal · doi:10.1093/eurheartj/3.suppl_a.49 · Cited by 233 · see citing works
The effects of stimulation of the left atrial receptors on sympathetic efferent nerve activity
Karim, F., Kidd, C., Malpus, C. M., & Penna, P. E. (1972) · The Journal of Physiology · doi:10.1113/jphysiol.1972.sp010030 · Cited by 220 · see citing works
Age-related changes in muscle sympathetic nerve activity in essential hypertension
Yamada, Y., Miyajima, E., Tochikubo, O., Matsukawa, T., & Ishii, M. (1989) · Hypertension · doi:10.1161/01.hyp.13.6.870 · Cited by 220 · see citing works
Verdecchia, P., Reboldi, G., Schillaci, G., Borgioni, C., Ciucci, A., Telera, M. P., Santeusanio, F., Porcellati, C., & Brunetti, P. (1999) · Circulation · doi:10.1161/01.cir.100.17.1802 · Cited by 186 · see citing works
Sex-specific determinants of increased left ventricular mass in the Tecumseh blood pressure study
Marcus, R., Krause, L., Weder, A. B., Dominguez-Meja, A., Schork, N. J., & Julius, S. (1994) · Circulation · doi:10.1161/01.cir.90.2.928 · Cited by 174 · see citing works
Single-Unit Sympathetic Discharge: Quantitative Assessment in Human Hypertensive Disease
Greenwood, J. P., Stoker, J. B., & Mary, D. A. S. G. (1999) · Circulation · doi:10.1161/01.cir.100.12.1305 · Cited by 174 · see citing works
Self-citationMuscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism.
Miyajima, E., Yamada, Y., Yoshida, Y., Matsukawa, T., Shionoiri, H., Tochikubo, O., & Ishii, M. (1991) · Hypertension · doi:10.1161/01.hyp.17.6.1057 · Cited by 163 · see citing works
Wallin, B. G., & Sundlöf, G. (1979) · Hypertension · doi:10.1161/01.hyp.1.2.67 · Cited by 144 · see citing works
Lauer, M. S., Anderson, K. M., & Levy, D. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90549-o · Cited by 143 · see citing works
Duprez, D. A., Bauwens, F. R., De Buyzere, M. L., De Backer, T. L., Kaufman, J. M., Van Hoecke, J., Vermeulen, A., & Clement, D. L. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90240-d · Cited by 139 · see citing works
Sympathoneural and haemodynamic characteristics of young subjects with mild essential hypertension
Floras, J. S., & Hara, K. (1993) · Journal of Hypertension · doi:10.1097/00004872-199306000-00009 · Cited by 137 · see citing works
Left ventricular hypertrophy as a risk factor in arterial hypertension
Kannel, W. B. (1992) · European Heart Journal · doi:10.1093/eurheartj/13.suppl_d.82 · Cited by 116 · see citing works
Harrap, S. B., Dominiczak, A. F., Fraser, R., Lever, A. F., Morton, J. J., Foy, C. J., & Watt, G. C. M. (1996) · Circulation · doi:10.1161/01.cir.93.6.1148 · Cited by 109 · see citing works
Left ventricular mass is linked to cardiac noradrenaline in normotensive and hypertensive patients
Kelm, M., Sch??fer, S., Mingers, S., Heydthausen, M., Vogt, M., Motz, W., & Strauer, B. E. (1996) · Journal of Hypertension · doi:10.1097/00004872-199611000-00015 · Cited by 97 · see citing works
Elevated sympathetic nerve activity in patients with accelerated essential hypertension.
Matsukawa, T., Mano, T., Gotoh, E., & Ishii, M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116558 · Cited by 94 · see citing works
Sympathetic outflow to muscles during treatment of hypertension with metoprolol
Wallin, B. G., Sundlöf, G., Strömgren, E., & Aberg, H. (1984) · Hypertension · doi:10.1161/01.hyp.6.4.557 · Cited by 86 · see citing works
Increased regional sympathetic nervous activity in human hypertension: causes and consequences.
Esler, M., Lambert, G. W., & Jennings, G. (1990) · PubMed · Cited by 84 · see citing works
Grassi, G., Turri, C., DellʼOro, R., Stella, M. L., Bolla, G. B., & Mancia, G. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816120-00012 · Cited by 77 · see citing works
Bauwens, F. R., Duprez, D. A., De Buyzere, M. L., De Backer, T. L., Kaufman, J. M., Van Hoecke, J., Vermeulen, A., & Clement, D. L. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90410-m · Cited by 70 · see citing works
Sympathetic Nerve Activity and Insulin in Obese Normotensive and Hypertensive Men
Guðbjörnsdóttir, S., Lönnroth, P., Sverrisdóttir, Y. B., Wallin, B. G., & Elam, M. (1996) · Hypertension · doi:10.1161/01.hyp.27.2.276 · Cited by 65 · see citing works
Matsukawa, T., Gotoh, E., Hasegawa, O., Shionoiri, H., Tochikubo, O., & Ishii, M. (1991) · Journal of Hypertension · doi:10.1097/00004872-199106000-00009 · Cited by 65 · see citing works
Effect of sympathetic overactivity on cardiovascular prognosis in hypertension.
Julius, S. (1998) · PubMed · Cited by 60 · see citing works
The relation of cell volume, cell sodium and the transmembrane sodium gradient to blood pressure
Friedman, S. M. (1990) · Journal of Hypertension · doi:10.1097/00004872-199001000-00011 · Cited by 47 · see citing works
Gueyffier, F., Boissel, J.-P., Pocock, S., Boutitie, F., Coope, J., Cutler, J., Ekbom, T., Fagard, R., Friedman, L., Kerlikowske, K., et al. (1999) · Circulation · doi:10.1161/01.cir.100.18.e88 · Cited by 46 · see citing works
Regulation of sympathetic nerve activity in mild human hypertension.
Mark, A. L. (1990) · PubMed · Cited by 39 · see citing works
Wright, C., Drinkhill, M. J., & Hainsworth, R. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00349.x · Cited by 29 · see citing works
Diabetic nephropathy in normotensive patients
Mimran, A., & Ribstein, J. (1990) · Journal of Hypertension · doi:10.1097/00004872-199003001-00011 · Cited by 28 · see citing works
Cardiovascular hypertrophy in spontaneously hypertensive rats.
Şen, S., & Rc, T. (1986) · PubMed · Cited by 20 · see citing works
BRAHIMI, M., LEVY, B. I., SAFAR, M. E., & DABIRÉ, H. (1998) · Clinical Science · doi:10.1042/cs0950261 · Cited by 9 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- Esler, 1990, Increased regional sympathetic nervous activity in human hypertension, J Hypertens, 8, S53
- Greenwood, 1998, Effect of atenolol therapy on peripheral sympathetic nerve discharge in essential hypertension, J Hypertens, 16, S240
Cited by
Sorted by citations
The Autonomic Nervous System and Hypertension
Mancia, G., & Grassi, G. (2014) · Circulation Research · doi:10.1161/circresaha.114.302524 · Cited by 627 · see citing works
The Sympathetic Nervous System Alterations in Human Hypertension
Grassi, G., Mark, A., & Esler, M. (2015) · Circulation Research · doi:10.1161/circresaha.116.303604 · Cited by 616 · see citing works
Relation Between Cardiac Sympathetic Activity and Hypertensive Left Ventricular Hypertrophy
Schlaich, M. P., Kaye, D. M., Lambert, E., Sommerville, M., Socratous, F., & Esler, M. D. (2003) · Circulation · doi:10.1161/01.cir.0000081775.72651.b6 · Cited by 459 · see citing works
Assessment of Sympathetic Cardiovascular Drive in Human Hypertension
Grassi, G. M. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.119883 · Cited by 340 · see citing works
Impact of Type 2 Diabetes Mellitus on Sympathetic Neural Mechanisms in Hypertension
Huggett, R. J., Scott, E. M., Gilbey, S. G., Stoker, J. B., Mackintosh, A. F., & Mary, D. A. S. G. (2003) · Circulation · doi:10.1161/01.cir.0000103123.66264.fe · Cited by 305 · see citing works
Self-citationSympathetic hyperactivity in chronic kidney disease: Pathogenesis, clinical relevance, and treatment
Neumann, J., Ligtenberg, G., Klein, I. H. H. T., Koomans, H. A., & Blankestijn, P. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00552.x · Cited by 302 · see citing works
Ma, J., Li, Y., Yang, X., Liu, K., Zhang, X., Zuo, X., Ye, R., Wang, Z., Shi, R., Meng, Q., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01430-7 · Cited by 257 · see citing works
Sympathetic Neural Activity in Hypertension and Related Diseases
Grassi, G. M. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2010.154 · Cited by 225 · see citing works
Relationship between central sympathetic activity and stages of human hypertension
Smith, P. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.10.010 · Cited by 215 · see citing works
Sympathetic Hyperactivity in Chronic Renal Failure
Koomans, H. A., Blankestijn, P. J., & Joles, J. A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000113320.57127.b9 · Cited by 203 · see citing works
Grassi, G., Seravalle, G., Quarti-Trevano, F., Dell'Oro, R., Arenare, F., Spaziani, D., & Mancia, G. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.121467 · Cited by 194 · see citing works
Evidence for a critical role of the sympathetic nervous system in hypertension
Grassi, G. M., & Ram, V. S. (2016) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2016.02.015 · Cited by 186 · see citing works
Świerblewska, E., Hering, D., Kára, T., Kunicka, K. B., Kruszewski, P., Bieniaszewski, L., Boutouyrie, P., Somers, V. K., & Narkiewicz, K. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328336ed9a · Cited by 171 · see citing works
Cardiac hypertrophy induced by sustained β-adrenoreceptor activation: pathophysiological aspects
Osadchii, O. E. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9007-4 · Cited by 164 · see citing works
Sympathetic neural mechanisms in white-coat hypertension
Smith, P. A., Graham, L. N., Mackintosh, A. F., Stoker, J. B., & Mary, D. A. S. G. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01931-9 · Cited by 146 · see citing works
Self-citationSympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates
Grassi, G. M., Pisano, A., Bolignano, D., Seravalle, G., D’Arrigo, G., Quarti‐Trevano, F., Mallamaci, F., Zoccali, C., & Mancia, G. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11038 · Cited by 140 · see citing works
Mano, T., Iwase, S., & Toma, S. (2006) · Clinical Neurophysiology · doi:10.1016/j.clinph.2006.06.002 · Cited by 138 · see citing works
Norepinephrine and Concentric Hypertrophy in Patients With End-Stage Renal Disease
Zoccali, C., Mallamaci, F., Tripepi, G. L., Parlongo, S., Cutrupi, S., Benedetto, F. A., Cataliotti, A., & Malatino, L. (2002) · Hypertension · doi:10.1161/01.hyp.0000022063.50739.60 · Cited by 136 · see citing works
Hypertension in chronic kidney disease: What lies behind the scene
Ameer, O. Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.949260 · Cited by 158 · see citing works
Sympathetic Overdrive and Cardiovascular Risk in the Metabolic Syndrome
Grassi, G. M. (2006) · Hypertension Research · doi:10.1291/hypres.29.839 · Cited by 131 · see citing works
Burns, J., Sivananthan, M. U., Ball, S. G., Mackintosh, A. F., Mary, D. A. S. G., & Greenwood, J. P. (2007) · Circulation · doi:10.1161/circulationaha.106.668863 · Cited by 122 · see citing works
Self-citationGrassi, G. M., Bombelli, M., Brambilla, G., Trevano, F. Q., Dell’Oro, R., & Mancia, G. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0273-8 · Cited by 89 · see citing works
Relationship of Insulin Sensitivity and Left Ventricular Mass in Uncomplicated Obesity
Iacobellis, G., Ribaudo, M. C., Zappaterreno, A., Vecci, E., Tiberti, C., Mario, U. D., & Leonetti, F. (2003) · Obesity Research · doi:10.1038/oby.2003.73 · Cited by 82 · see citing works
The magnitude of sympathetic hyperactivity in pregnancy-induced hypertension and preeclampsia
Greenwood, J. P. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)03256-9 · Cited by 77 · see citing works
Self-citationFinnell, J. E., Muniz, B. L., Padi, A. R., Lombard, C. M., Moffitt, C. M., Wood, C. S., Wilson, L. B., Reagan, L. P., Wilson, M. A., & Wood, S. K. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.01.013 · Cited by 75 · see citing works
Antunes‐Correa, L. M., Kanamura, B. Y., de Melo, R. C., Nobre, T. S., Ueno, L. M., Franco, F. G. M., Roveda, F., Braga, A. M., Rondon, M. U. P. B., Brum, P. C., et al. (2011) · European Journal of Preventive Cardiology · doi:10.1177/1741826711414626 · Cited by 75 · see citing works
The role of non-haemodynamic factors of the genesis of LVH
Schmieder, R. E. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfi190 · Cited by 74 · see citing works
Struck, J., Muck, P. M., Trübger, D., Handrock, R., Weidinger, G., Dendorfer, A., & Dodt, C. (2002) · Journal of Hypertension · doi:10.1097/00004872-200206000-00026 · Cited by 73 · see citing works
Cardiac remodeling in systemic hypertension
Kenchaiah, S., & Pfeffer, M. A. (2004) · Medical Clinics of North America · doi:10.1016/s0025-7125(03)00168-8 · Cited by 73 · see citing works
Yadav, R. D., Raisingani, D., Jindal, D., & Mathur, R. (2016) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1364 · Cited by 72 · see citing works
Raj, S., Agarwal, M., Aradhya, K., Konde, S., & Nagakishore, V. (2013) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1178 · Cited by 66 · see citing works
Grassi, G. M., Seravalle, G., Turri, C., Bolla, G. B., & Mancia, G. (2003) · Hypertension · doi:10.1161/01.hyp.0000058003.27729.5a · Cited by 64 · see citing works
Cardiovascular risk and adrenergic overdrive in the metabolic syndrome
Grassi, G. M., Quarti‐Trevano, F., Seravalle, G., & Dell’Oro, R. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.01.004 · Cited by 61 · see citing works
Gq-Coupled Receptor Agonists Mediate Cardiac Hypertrophy Via the Vasculature
Keys, J. R., Greene, E. A., Koch, W. J., & Eckhart, A. D. (2002) · Hypertension · doi:10.1161/01.hyp.0000035397.73223.ce · Cited by 60 · see citing works
Strand, A. H., Gudmundsdottir, H., Os, I., Smith, G., Westheim, A. S., Bjørnerheim, R., & Kjeldsen, S. E. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000222761.07477.7b · Cited by 58 · see citing works
Is kidney ischemia the central mechanism in parallel activation of the renin and sympathetic system?
Siddiqi, L., Joles, J. A., Grassi, G. M., & Blankestijn, P. J. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832b521b · Cited by 55 · see citing works
Somani, R., Jaidka, S., Singh, D. J., & Sibal, G. K. (2016) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1362 · Cited by 55 · see citing works
Seravalle, G., Mancia, G., & Grassi, G. M. (2014) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-014-0056-1 · Cited by 53 · see citing works
Sympathetic Mechanisms, Organ Damage, and Antihypertensive Treatment
Grassi, G. M., Seravalle, G., Dell’Oro, R., & Mancia, G. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0200-4 · Cited by 53 · see citing works
Macefield, V. G., & Wallin, B. G. (2017) · Journal of Neurophysiology · doi:10.1152/jn.00004.2017 · Cited by 47 · see citing works
Smith, P. A., Meaney, J. F., Graham, L., Stoker, J. B., Mackintosh, A., Mary, D., & Ball, S. G. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.047 · Cited by 42 · see citing works
Self-citationMurai, H., Takata, S., Maruyama, M., Nakano, M., Kobayashi, D., Otowa, K., Takamura, M., Yuasa, T., Sakagami, S., & Kaneko, S. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00184.2005 · Cited by 41 · see citing works
Metformin Inhibits Isoproterenol-induced Cardiac Hypertrophy in Mice
Cha, H.-N., Choi, J. H., Kim, Y., Kim, J., Ahn, M.-W., & Park, S. (2010) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2010.14.6.377 · Cited by 39 · see citing works
Is there an Association between Oral Health Status and School Performance? A Preliminary Study
Garg, N., Anandakrishna, L., & Chandra, P. (2012) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1150 · Cited by 37 · see citing works
Siddiqi, L., Prakken, N. H. J., Velthuis, B. K., Cramer, M. J., Oey, P. L., de Boer, P., Bots, M. L., & Blankestijn, P. J. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq175 · Cited by 36 · see citing works
Vink, E. E., & Blankestijn, P. J. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00029 · Cited by 35 · see citing works
Carrillo, E. D., Escobar, Y., González, G., Hernández, A., Galindo, J. M., García, M. C., & Sánchez, J. A. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31822a789b · Cited by 35 · see citing works
Acute Effects of a Mixed Meal on Arterial Stiffness and Central Hemodynamics in Healthy Adults
Taylor, J. L., Curry, T. B., Matzek, L. J., Joyner, M. J., & Casey, D. P. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt211 · Cited by 34 · see citing works
Characteristics of Primary Dentition Occlusion in Preschool Children: An Epidemiological Study
Bhat, S. S., Rao, H. A., Hegde, K. S., & Kumar, B. K. (2012) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1143 · Cited by 34 · see citing works
Mechanisms and Subclinical Consequences of Aortic Stiffness
Pierce, G. L. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.08933 · Cited by 33 · see citing works
Xu, J., Molinas, A., Mukerjee, S., Morgan, D. A., Rahmouni, K., Zsombok, A., & Lazartigues, E. D. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12832 · Cited by 31 · see citing works
The activity of single vasoconstrictor nerve units in hypertension
Mary, D. A. S. G., & Stoker, J. B. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01082.x · Cited by 32 · see citing works
Self-citationPerticone, F., Maio, R., Ruberto, C., Cassano, S., Tripepi, G. L., Perticone, M., Sesti, G., & Zoccali, C. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.02.302 · Cited by 29 · see citing works
Success Rate of MTA Pulpotomy on Vital Pulp of Primary Molars: A 3-Year Observational Study
Godhi, B. S., & Tyagi, R. (2016) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1368 · Cited by 29 · see citing works
Gallego‐Delgado, J., Lázaro, A., Osende, J. I., Barderas, M. G., Durán-Ruiz, M. C., Vivanco, F., & Egido, J. (2005) · Journal of Proteome Research · doi:10.1021/pr0503275 · Cited by 28 · see citing works
Grassi, G. M., Seravalle, G., Brambilla, G., & Mancia, G. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.11.005 · Cited by 27 · see citing works
Katz, D. H., Tahir, U. A., Ngo, D., Benson, M. D., Gao, Y. L., Shi, X. D., Nayor, M. G., Keyes, M. J., Larson, M. G., Hall, M. E., et al. (2021) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.120.003191 · Cited by 27 · see citing works
Resting sympathetic outflow does not predict the morning blood pressure surge in hypertension
Hering, D., Kucharska, W., Kára, T., Somers, V. K., & Narkiewicz, K. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834c1ecd · Cited by 27 · see citing works
Yadav, G., Rehani, U., & Rana, V. (2012) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1145 · Cited by 27 · see citing works
Hypertensive left ventricular hypertrophy
Burns, J., Ball, S. G., Worthy, G., Struthers, A. D., Mary, D., & Greenwood, J. P. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328356b850 · Cited by 26 · see citing works
Self-citationRegression of left ventricular hypertrophy is a key goal of hypertension management
Zhang, R., Crump, J., & Reisin, E. (2003) · Current Hypertension Reports · doi:10.1007/s11906-003-0038-5 · Cited by 25 · see citing works
Ventricular hypertrophy increases NT-proBNP in subjects with and without hypertension
Otero, J. M. R., Taléns‐Visconti, R., Salvador, A., Bertoméu, V., Miró, V., Jordán, A. J., Sogorb, F., Cortés, R., Payá, R., Diago, J. L., et al. (2003) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.07.019 · Cited by 25 · see citing works
Internal and External Root Resorption Management: A Report of Two Cases
Hegde, N., & Hegde, M. N. (2013) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1186 · Cited by 24 · see citing works
Blankestijn, P. J., & Ligtenberg, G. (2004) · Seminars in Dialysis · doi:10.1111/j.0894-0959.2004.17324.x · Cited by 23 · see citing works
Iron Deficiency in Young Children: A Risk Marker for Early Childhood Caries
Akkareddy, B., Koppal, P. I., Sakri, M. R., Hinduja, D., Gangolli, R. A., & Patil, B. C. (2013) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1176 · Cited by 22 · see citing works
Hamaoka, T., Murai, H., Kaneko, S., Usui, S., Okabe, Y., Tokuhisa, H., Kato, T., Furusho, H., Sugiyama, Y., Nakatsumi, Y., et al. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00066 · Cited by 22 · see citing works
Pathak, S., Shashibhushan, K. K., Poornima, P., & Reddy, V. S. (2016) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1363 · Cited by 22 · see citing works
Effect of Propolis on Streptococcus mutans Counts: An in vivo Study
Hegde, K. S., Bhat, S. S., Rao, A., & Sain, S. (2013) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1180 · Cited by 21 · see citing works
Ripley, D. P., Negrou, K., Oliver, J. J., Worthy, G., Struthers, A. D., Plein, S., & Greenwood, J. P. (2014) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2014.960974 · Cited by 21 · see citing works
Self-citationThe sympathetic nervous system in renovascular hypertension: lead actor or ‘bit’ player?
Grassi, G. M., & Esler, M. (2002) · Journal of Hypertension · doi:10.1097/00004872-200206000-00013 · Cited by 20 · see citing works
Genetic mouse models of autism spectrum disorder present subtle heterogenous cardiac abnormalities
Assimopoulos, S., Hammill, C. F., Fernandes, D., Noakes, T. L. S., Zhou, Y., Nutter, L. M. J., Ellegood, J., Anagnostou, E. A., Sled, J. G., & Lerch, J. P. (2022) · Autism Research · doi:10.1002/aur.2728 · Cited by 18 · see citing works
Baroreflex activation therapy systems: current status and future prospects
Seravalle, G., Dell’Oro, R., & Grassi, G. M. (2019) · Expert Review of Medical Devices · doi:10.1080/17434440.2019.1697230 · Cited by 18 · see citing works
Ahmad, A., Sattar, M. Z. A., Azam, M., Khan, S. A., Bhatt, O., & Johns, E. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0189386 · Cited by 18 · see citing works
Prabhakar, A., Pattanshetti, K., & Sugandhan, S. (2013) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1181 · Cited by 18 · see citing works
Swadas, M., Dave, B., Vyas, S. M., & Shah, N. (2016) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1360 · Cited by 18 · see citing works
Sympathetic modulation as a goal of antihypertensive treatment: from drugs to devices
Grassi, G. M. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003538 · Cited by 17 · see citing works
Resistant Hypertension and Renal Nerve Denervation
Denker, M. G., & Cohen, D. L. (2015) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-11-4-240 · Cited by 17 · see citing works
A Study of Bite Force and Various Variables in Children Segregated by Angle's Classification
Singh, S., Sandhu, N., & Kashyap, R. (2012) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1148 · Cited by 16 · see citing works
Complete and Removable Partial Prosthesis for a Child with Hypohidrotic Ectodermal Dysplasia
Trivedi, B., & Bhatia, R. (2013) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1192 · Cited by 16 · see citing works
The central sympathetic nervous system in hypertension
Mancia, G., & Grassi, G. M. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53491-0.00026-2 · Cited by 14 · see citing works
Gupta, S., Bansal, R., Pathak, A. K., Bhatia, B., & Gautam, K. K. (2012) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1154 · Cited by 15 · see citing works
Vinay, S., Keshav, V., & Sankalecha, S. (2012) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1144 · Cited by 15 · see citing works
Cardiac Target Organ Damage in Hypertension: Insights from Epidemiology
Lawler, P. R., Hiremath, P. G., & Cheng, S. C. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0446-8 · Cited by 15 · see citing works
Hypertensive left ventricular hypertrophy
Park, S., Choi, D., & Kim, C. W. (2004) · Journal of Hypertension · doi:10.1097/00004872-200405000-00026 · Cited by 14 · see citing works
Grassi, G. M. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000222748.37078.2d · Cited by 14 · see citing works
Primary Oral Health Care in India: Vision or Dream?
Suresh, K. S., Kumar, P., Nagarathna, J., Shantappa, S., & Srivastava, P. (2016) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1369 · Cited by 13 · see citing works
Applicability of Bolton's Analysis: A Study on Jaipur Population
Trehan, M., Agarwal, S., & Sharma, S. D. (2012) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1147 · Cited by 13 · see citing works
Increased Platelet Aggregation in Children and Adolescents with Sleep-disordered Breathing
Kontos, A., Willoughby, S., Lushington, K., Martin, J. M., Wabnitz, D. A. M., Dorrian, J., & Kennedy, D. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201911-2229oc · Cited by 13 · see citing works
Rathore, H. A., Munavvar, A. S., Abdullah, N. A., Khan, A. H., Basri, F., NurJannah, M. H., Raisa, N. A., Swarup, K. R. L. A., Abdullah, M. H., Salman, I. M., et al. (2009) · Autonomic and Autacoid Pharmacology · doi:10.1111/j.1474-8665.2009.00445.x · Cited by 12 · see citing works
Oral Melanoacanthoma of a Rare Intraoral Site: Case Report and Review of Literature
Singh, N., Ramesh, V., Rohilla, K., & Balamurali, P. (2013) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1185 · Cited by 12 · see citing works
Comparative Evaluation of Remineralizing Potential of Three Pediatric Dentifrices
Kapoor, A., Indushekar, K., Saraf, B. G., Sheoran, N., & Sardana, D. (2016) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1361 · Cited by 12 · see citing works
Hassan, A. F., Yadav, G., Tripathi, A. M., Mehrotra, M., Saha, S., & Garg, N. (2016) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1366 · Cited by 12 · see citing works
Giannakidis, A., Rohmer, D., Veress, A. I., & Gullberg, G. T. (2012) · doi:10.1002/9781118481585.ch53 · Cited by 12 · see citing works
Dens Invaginatus in Primary Maxillary Molar: A Rare Case Report and Review of Literature
Bansal, A. V., Bansal, A., Kulkarni, V. K., & Dhar, R. S. (2012) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1152 · Cited by 11 · see citing works
Evaluation of the Microleakage of Chlorhexidine-Modified Glass Ionomer Cement: An in vivo Study
Mathew, S. M., Thomas, A. M., Koshy, G., & Dua, K. (2013) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1177 · Cited by 11 · see citing works
Zheng, W., Mu, J., Yan, Y., Chu, C., Su, X., Ren, Y., Chen, F., & Luo, D. (2022) · Hypertension Research · doi:10.1038/s41440-022-01076-y · Cited by 11 · see citing works
Srivastava, B., Bhatia, H. P., Chaudhary, V., Aggarwal, A., Singh, A. K., & Gupta, N. (2012) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1146 · Cited by 11 · see citing works
Renal denervation in dialysis patients: long-term outcomes in a real-world setting
Gangemi, C., Gambaro, A., Ortalda, V., Tavella, D., Caletti, C., Fezzi, S., Bianco, B., Tomi, E. D., Gambaro, G., Ribichini, F. L., et al. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf149 · Cited by 10 · see citing works
Agenesis of Multiple Primary Teeth and Its Rehabilitation: A Case Report
Nirmala, S., Gokhale, N., Sivakumar, N., & Quadar, M. A. (2013) · International Journal of Clinical Pediatric Dentistry · doi:10.5005/jp-journals-10005-1188 · Cited by 10 · see citing works
Osadchii, O. E. (2018) · Кубанский научный медицинский вестник · doi:10.25207/1608-6228-2018-25-1-180-188 · Cited by 10 · see citing works
- Authors
- Greenwood, J. P., Scott, E. M., Stoker, J. B., & Mary, D. A. S. G.
- Affiliations
- St James's University Hospital (GB)
- Corresponding author
- Greenwood, John P
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2001-11
- Volume
- 38
- Issue
- 6
- Pages
- 1711-1717
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2063781207
- Cited by
- 161
- References
- 43
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 5 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 7 · 2017: 3 · 2016: 15 · 2015: 6 · 2014: 5 · 2013: 20 · 2012: 25
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- left ventricular hypertrophy, essential hypertension, peripheral sympathetic nervous system, muscle sympathetic nerve activity, sympathetic nerve discharge, catecholamines, peroneal nerve, fiber recruitment
- MeSH terms
- Action Potentials, Analysis of Variance, Humans, Hypertension, Sympathetic Nervous System, Vasoconstriction, Least-Squares Analysis, Case-Control Studies, Hypertrophy, Left Ventricular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review